Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Affinor Growers Inc
C.AFI
Alternate Symbol(s):
RSSFF
Consumer Defensive
Packaged Foods
Affinor Growers Inc. is a Canada-based vertical farming technology and greenhouse operations company. The Company is a patented technology developer and supplier of turnkey vertical farming facilities, including proprietary greenhouse, growing towers, automation and cultivation processes. It is focused on developing vertical farming technologies and using those technologies to grow fruits and vegetables in a sustainable manner. The Company has vertically integrated growing systems that can offer automated mechanical pollination for fruiting crops and vertical solutions for the vertical farming industry. It has an expansion plan to grow strawberries, romaine lettuce, kale and spinach across Western Canada. It is growing strawberries at four levels in a 15,000 square foot leased greenhouse in Abbotsford, British Columbia. It has developed and patented its own growing towers in Canada, the United States, Colombia and Aruba.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
New Post
CSE:AFI - Post by User
Affinor Growers Inc
Bullboard Posts
(5)
•••
NotSoWallStreet
X
View Profile
View Bullboard History
Post by
NotSoWallStreet
on Jul 10, 2020 12:53pm
154 Views
Post# 31252307
!@AFI LOAD UP SHARES &$#
!@AFI LOAD UP SHARES &$#
will be laoding up around 0.025 very soon either just before close today , or next weeks dip GL
Comment on this Post
Bullboard Posts
Crypto and blockchain stock ends year with a profit
Full Circle Lithium goes global with its battery fire-fighter
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide
NervGen Pharma: Proof that NVG-291 works?
3 Mid-Sized Stocks to Consider This Season
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
{{ dialogTitle }}
×
Reject Reason
{{ policy.description }}
{{reasonError}}
Additional Comments
{{feedbackError}}
{{buttonTitle}}
Cancel
{{submitMsg}}
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.